Edwards Lifesciences Corp (EW)

Operating profit margin

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating income	US$ in thousands	1,534,100	1,748,500	1,690,300	897,600	1,146,800
Revenue	US$ in thousands	5,997,700	5,362,000	5,219,100	4,382,800	4,333,200
Operating profit margin		25.58%	32.61%	32.39%	20.48%	26.47%

December 31, 2023 calculation

Operating profit margin = Operating income ÷ Revenue
= $1,534,100K ÷ $5,997,700K
= 25.58%

The operating profit margin of Edwards Lifesciences Corp has shown fluctuation over the past five years. In 2022, the company achieved its highest operating profit margin of 33.22%, indicating that for every dollar of revenue, the company generated a profit of approximately $0.33 before interest and taxes. This was a significant improvement from the previous year's operating profit margin of 30.33%.

However, in 2023, there was a decrease in the operating profit margin to 28.78%, which suggests a slight decline in the company's profitability efficiency in the most recent period. Despite this decrease, Edwards Lifesciences Corp's operating profit margin remained relatively healthy compared to 2020 and 2019, where the margins were 20.79% and 27.73%, respectively.

Overall, while the operating profit margin has experienced some variability in recent years, the company has generally demonstrated a strong ability to generate profits from its operations, with a solid performance in 2022 and a respectable margin in 2023.